Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Net Income (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Net Income data on record, last reported at -$48.2 million in Q3 2025.

  • For Q3 2025, Net Income fell 56.37% year-over-year to -$48.2 million; the TTM value through Sep 2025 reached -$158.8 million, down 114.95%, while the annual FY2024 figure was -$56.5 million, 68.56% up from the prior year.
  • Net Income reached -$48.2 million in Q3 2025 per GOSS's latest filing, down from -$38.3 million in the prior quarter.
  • Across five years, Net Income topped out at $53.7 million in Q2 2024 and bottomed at -$59.0 million in Q3 2022.
  • Average Net Income over 4 years is -$39.8 million, with a median of -$44.7 million recorded in 2024.
  • Peak YoY movement for Net Income: surged 226.29% in 2024, then plummeted 171.32% in 2025.
  • A 4-year view of Net Income shows it stood at -$57.2 million in 2022, then increased by 9.2% to -$52.0 million in 2023, then skyrocketed by 36.43% to -$33.0 million in 2024, then plummeted by 46.0% to -$48.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were -$48.2 million in Q3 2025, -$38.3 million in Q2 2025, and -$39.3 million in Q1 2025.